Envestnet Asset Management Inc. Grows Stock Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

Envestnet Asset Management Inc. raised its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 17.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 32,707 shares of the company’s stock after acquiring an additional 4,954 shares during the period. Envestnet Asset Management Inc.’s holdings in Surgery Partners were worth $692,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of SGRY. Wells Fargo & Company MN boosted its position in shares of Surgery Partners by 1.4% during the fourth quarter. Wells Fargo & Company MN now owns 56,931 shares of the company’s stock valued at $1,205,000 after buying an additional 783 shares during the last quarter. MeadowBrook Investment Advisors LLC lifted its stake in shares of Surgery Partners by 16.6% in the 4th quarter. MeadowBrook Investment Advisors LLC now owns 10,280 shares of the company’s stock worth $218,000 after purchasing an additional 1,460 shares during the period. KBC Group NV boosted its holdings in shares of Surgery Partners by 66.1% in the fourth quarter. KBC Group NV now owns 3,962 shares of the company’s stock worth $84,000 after buying an additional 1,577 shares during the last quarter. Rhumbline Advisers grew its position in shares of Surgery Partners by 1.3% during the 4th quarter. Rhumbline Advisers now owns 121,852 shares of the company’s stock valued at $2,580,000 after acquiring an additional 1,588 shares during the period. Finally, LPL Financial LLC lifted its holdings in Surgery Partners by 22.4% during the fourth quarter. LPL Financial LLC now owns 16,749 shares of the company’s stock valued at $355,000 after purchasing an additional 3,062 shares in the last quarter.

Wall Street Analyst Weigh In

A number of research firms have commented on SGRY. Macquarie decreased their price target on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating on the stock in a report on Tuesday, March 11th. Benchmark restated a “buy” rating and set a $35.00 price target on shares of Surgery Partners in a report on Monday, April 21st. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $35.00 target price on shares of Surgery Partners in a report on Tuesday, March 25th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $34.75.

Surgery Partners Trading Up 2.9 %

Shares of SGRY opened at $23.08 on Friday. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99. The company has a market cap of $2.95 billion, a P/E ratio of -48.08, a P/E/G ratio of 19.21 and a beta of 2.40. Surgery Partners, Inc. has a twelve month low of $19.50 and a twelve month high of $33.97. The company’s fifty day simple moving average is $22.75 and its 200-day simple moving average is $23.80.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Monday, March 3rd. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.01. The company had revenue of $864.40 million during the quarter, compared to analysts’ expectations of $828.09 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. As a group, analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current year.

Insider Buying and Selling

In other Surgery Partners news, insider Harrison R. Bane sold 56,315 shares of the stock in a transaction on Friday, February 7th. The stock was sold at an average price of $25.64, for a total transaction of $1,443,916.60. Following the sale, the insider now owns 107,037 shares of the company’s stock, valued at approximately $2,744,428.68. This trade represents a 34.47 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Marissa Brittenham sold 3,156 shares of the company’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $24.09, for a total value of $76,028.04. Following the sale, the insider now owns 63,408 shares of the company’s stock, valued at $1,527,498.72. This trade represents a 4.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 106,622 shares of company stock valued at $2,717,860 over the last three months. 2.30% of the stock is owned by company insiders.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.